Append Medical: Funding, Investors & Team (Sep 2026)
Append Medical is currently developing a cutting-edge LAA closure system through their pre-clinical in-vivo trial phase. The company aims to create a unique solution for the LAA closure market, which is predicted to expand to a value of $25 billion in the coming years. This market segment is among the fastest growing in the medical device industry, with potential sales of $500 million projected for 2019. Append Medical is affiliated with MEDX Xelerator, a medtech incubator supported by Boston Scientific, Intellectual Ventures, MEDX Ventures, and Sheba Medical Center.
Append Medical has raised $11.8M across 2 funding rounds on record, the most recent a Series A of $4.4M announced in Jul 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Append Medical Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Append Medical Funding Rounds
Append Medical raised $7.4M in a Series A announced in Aug 2021.
1.9 years later, a Series A of $4.4M was announced in Jul 2023.
Append Medical Founders and Leadership Team
Contact details for the Append Medical team: 1 of 1 has an email address on file.
Start 14-day free trial →Append Medical Funding Compared to Other Biotechnology Startups
Append Medical's latest round of $4.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Append Medical in Biotechnology and Or Yehuda
Companies Similar to Append Medical
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Append Medical Funding FAQs
What does Append Medical do?
Append Medical is currently developing a cutting-edge LAA closure system through their pre-clinical in-vivo trial phase. The company aims to create a unique solution for the LAA closure market, which is predicted to expand to a value of $25 billion in the coming years. This market segment is among the fastest growing in the medical device industry, with potential sales of $500 million projected for 2019. Append Medical is affiliated with MEDX Xelerator, a medtech incubator supported by Boston Scientific, Intellectual Ventures, MEDX Ventures, and Sheba Medical Center.
How much funding has Append Medical raised?
Append Medical has raised $11.8M across 2 rounds on record. The most recent is a Series A of $4.4M announced in Jul 2023.
When did Append Medical last raise funding?
Append Medical's most recent funding round on record is a Series A of $4.4M, announced in Jul 2023.
Who is the CEO of Append Medical?
Zachi Berger is listed as CEO at Append Medical.
Where is Append Medical headquartered?
Append Medical is based in Or Yehuda, Tel Aviv, Israel.
How many employees does Append Medical have?
Append Medical is in the 11-50 employee band.
How does Append Medical's funding compare to other Biotechnology startups?
Append Medical's latest round of $4.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Append Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Append Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.